<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01326442</url>
  </required_header>
  <id_info>
    <org_study_id>2011MeckVitD</org_study_id>
    <nct_id>NCT01326442</nct_id>
  </id_info>
  <brief_title>Vitamin D and Omega-3 Inhibit Metabolic Syndrome</brief_title>
  <official_title>Phase 3 Study of Vitamin D and Omega-3 Supplementation to Reduce Risk of Metabolic Syndrome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Guelph</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Guelph</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study will test the hypothesis that supplementing the diet of subjects with Metabolic
      Syndrome with 2000 IU vitamin D and 1.8 g omega-3 fatty acids (EPA + DHA) per day, will
      facilitate weight loss, improve body composition and reduce metabolic and biochemical risk
      factors associated with type II diabetes and cardiovascular disease. Adult men and women who
      meet the International Diabetes Federation criteria for Metabolic Syndrome will be enrolled
      and embark on a 16 week diet and exercise intervention using a low glycemic index diet with
      or without the supplementary vitamin D and omega-3. Subjects will be counseled weekly and
      blood collected at weeks 0 and 16.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2011</start_date>
  <completion_date type="Actual">December 2012</completion_date>
  <primary_completion_date type="Actual">December 2012</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>body weight</measure>
    <time_frame>up to 16 weeks</time_frame>
    <description>body weight will be measured to nearest 0.5 kg weekly</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Blood pressure</measure>
    <time_frame>up to 16 weeks</time_frame>
    <description>systolic and diastolic blood pressure will be measured in duplicate, weekly</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood lipids</measure>
    <time_frame>up to 16 weeks</time_frame>
    <description>blood lipids will be measured at baseline and after study completion.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Glucose homeostasis</measure>
    <time_frame>up to 16 weeks</time_frame>
    <description>fasting blood glucose, insulin, HbA1c, CRP, cytokines and inflammatory markers will be measured at weeks 0 and 16 of the intervention.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Type 2 Diabetes Mellitus</condition>
  <condition>Hypertension</condition>
  <condition>Hyperlipidemia</condition>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>diet only</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>low glycemic index diet, calorie restricted with exercise 3 times per week.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>supplemented</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>2000 IU vitamin D3 plus 1.8 g EPA + DHA</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>low glycemic diet</intervention_name>
    <description>a low glycemic diet, calorie restricted with exercise sessions 3 times per week</description>
    <arm_group_label>diet only</arm_group_label>
    <arm_group_label>supplemented</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>vitamin D omega-3</intervention_name>
    <description>2000 IU vitamin D3 plus 1.8 g EPA + DHA per day for 16 weeks.</description>
    <arm_group_label>supplemented</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  must have Metabolic Syndrome as defined by International Diabetes Federation

          -  must be able to swallow tablets and capsules

          -  must be 18 years of age or older

          -  must be physically capable of moderate intensity exercise

        Exclusion Criteria:

          -  pregnant or lactating

          -  vegetarian
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kelly A Meckling, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Guelph</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Guelph</name>
      <address>
        <city>Guelph</city>
        <state>Ontario</state>
        <zip>N1G2W1</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>June 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 29, 2011</study_first_submitted>
  <study_first_submitted_qc>March 29, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 30, 2011</study_first_posted>
  <last_update_submitted>June 12, 2013</last_update_submitted>
  <last_update_submitted_qc>June 12, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 13, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Guelph</investigator_affiliation>
    <investigator_full_name>Kelly Anne Meckling, PhD</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>weight loss</keyword>
  <keyword>overweight</keyword>
  <keyword>body composition</keyword>
  <keyword>visceral obesity</keyword>
  <keyword>insulin</keyword>
  <keyword>glucose tolerance</keyword>
  <keyword>cholesterol</keyword>
  <keyword>hypertriglyceridemia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
    <mesh_term>Metabolic Syndrome X</mesh_term>
    <mesh_term>Hyperlipidemias</mesh_term>
    <mesh_term>Hyperlipoproteinemias</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Vitamin D</mesh_term>
    <mesh_term>Ergocalciferols</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

